Endotoxin is one of the few contaminants in a peptide preparation that can quietly wreck a cell-based experiment without ...
With the FDA’s rule in place, sponsors now have clearer regulatory footing to submit nonclinical data generated through validated alternative methods as part of IND and marketing applications, though ...
DOVER, DE, UNITED STATES, January 21, 2026 /EINPresswire.com/ — The global pharmaceutical supply chain is currently confronting a dual imperative: ensuring ...
DOVER, DE, UNITED STATES, June 9, 2026 /EINPresswire.com/ — The safety and quality control of parenteral pharmaceuticals, biologics, and medical devices depend ...
As thoroughly covered in your recent article (C&EN, Oct. 28, 2024, page 26), the issue of replacing the traditional natural product test for endotoxin, limulus amoebocyte lysate (LAL), with a ...
The presence of harmful bacteria in parenteral drugs or implantable devices can cause inflammatory responses such as fever and, in some cases, may even be fatal. As a result, robust bacterial ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results